Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

NCT05007860 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05007860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
July 16, 2020
Completion date
June 30, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia/small lymphocytic lymphoma